Prostate Cancer Reports
54

Volume 5 Number 6
June 2017



Home > Prostate Cancer Reports > Volume 5, Year 2017 > Number 6, June


CONTENTS



CASE REPORTS
DIAGNOSIS AND EVALUATION
EPIDEMIOLOGY, RISK FACTORS AND PREVENTION
FOLLOW-UP AND QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS AND OUTCOMES
TREATMENT





CASE REPORTS



Khan M, Davidson AJ, McKinley M, Ischia J.
Isolated prostate cancer soft tissue recurrence 10 years after radical prostatectomy.
BMJ Case Rep. 2017 May 12;2017. pii: bcr-2017-220140. doi: 10.1136/bcr-2017-220140.
Source | Abstract | Full text | Similar articles





DIAGNOSIS AND EVALUATION



Afshar-Oromieh A, Holland-Letz T, Giesel FL, Kratochwil C, Mier W, Haufe S, Debus N, Eder M, Eisenhut M, Schäfer M, Neels O, Hohenfellner M, Kopka K, Kauczor HU, Debus J, Haberkorn U.
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1258-1268. doi: 10.1007/s00259-017-3711-7. Epub 2017 May 12.
Source | Abstract | Full text | Similar articles




Bansal S, Gupta NP, Yadav R, Khera R, Ahlawat K, Gautam D, Ahlawat R, Gautam G.
Multiparametric magnetic resonance imaging-transrectal ultrasound fusion prostate biopsy: A prospective, single centre study.
Indian J Urol. 2017 Apr-Jun;33(2):134-139. doi: 10.4103/0970-1591.203414.
Source | Abstract | Full text | Similar articles




Fitzpatrick C, Lynch O, Marignol L.
68Ga-PSMA-PET/CT Has a Role in Detecting Prostate Cancer Lesions in Patients with Recurrent Disease.
Anticancer Res. 2017 Jun;37(6):2753-2760.
Source | Abstract | Full text | Similar articles




Hadaschik B, Herrmann K.
Re: Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-ligand-PET/CT Before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.
Eur Urol. 2017 May 15. pii: S0302-2838(17)30388-3. doi: 10.1016/j.eururo.2017.05.007. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Hope TA, Aggarwal R, Chee B, Tao D, Greene KL, Cooperberg M, Feng F, Chang A, Ryan CJ, Small EJ, Carroll PR.
Impact of Ga-68 PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.
J Nucl Med. 2017 May 18. pii: jnumed.117.192476. doi: 10.2967/jnumed.117.192476. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Jilg CA, Drendel V, Rischke HC, Beck T, Vach W, Schaal K, Wetterauer U, Schultze-Seemann W, Meyer PT.
Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.
Theranostics. 2017 Apr 10;7(6):1770-1780. doi: 10.7150/thno.18421. eCollection 2017.
Source | Abstract | Full text | Similar articles




Panda A.
Revisiting prostate cancer: Can we separate the wheat from the chaff?
Indian J Urol. 2017 Apr-Jun;33(2):97-98. doi: 10.4103/iju.IJU_95_17. Epub 2017 Mar 30.
Source | Abstract | Full text | Similar articles




Telloni SM.
Tumor Staging and Grading: A Primer.
Methods Mol Biol. 2017;1606:1-17. doi: 10.1007/978-1-4939-6990-6_1.
Source | Abstract | Full text | Similar articles




Witkowska-Patena E, Mazurek A, Dziuk M.
68Ga-PSMA PET/CT imaging in recurrent prostate cancer: Where are we now?
Cent European J Urol. 2017;70(1):37-43. doi: 10.5173/ceju.2017.947. Epub 2017 Jan 11.
Source | Abstract | Full text | Similar articles




Zumsteg ZS, Zelefsky MJ, Woo KM, Spratt DE, Kollmeier MA, McBride S, Pei X, Sandler HM, Zhang Z.
Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer.
BJU Int. 2017 May 2. doi: 10.1111/bju.13903. [Epub ahead of print]
Source | Abstract | Full text | Similar articles | Editor's choice





EPIDEMIOLOGY, RISK FACTORS AND PREVENTION



Lin WY, Chang YH, Lin CL, Kao CH, Wu HC.
Erectile dysfunction and the risk of prostate cancer.
Oncotarget. 2017 Apr 13. doi: 10.18632/oncotarget.17082. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Schnoeller TJ, Jentzmik F, Schrader AJ, Steinestel J.
Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness.
Oncotarget. 2017 Apr 7. doi: 10.18632/oncotarget.16943. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





FOLLOW-UP AND QUALITY OF LIFE



Chen YC, Lin PH, Jou YY, Lin VC.
Surgical treatment for urinary incontinence after prostatectomy: A meta-analysis and systematic review.
PLoS One. 2017 May 3;12(5):e0130867. doi: 10.1371/journal.pone.0130867. eCollection 2017.
Source | Abstract | Full text | Similar articles





INTEGRATIVE MEDICINE



Paller CJ, Pantuck A, Carducci MA.
A review of pomegranate in prostate cancer.
Prostate Cancer Prostatic Dis. 2017 Apr 25. doi: 10.1038/pcan.2017.19. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Pounis G, Tabolacci C, Costanzo S, Cordella M, Bonaccio M, Rago L, D'Arcangelo D, Filippo Di Castelnuovo A, de Gaetano G, Donati MB, Iacoviello L, Facchiano F; Moli-sani study investigators.
Reduction by coffee consumption of prostate cancer risk: Evidence from the Moli-sani cohort and cellular models.
Int J Cancer. 2017 Jul 1;141(1):72-82. doi: 10.1002/ijc.30720. Epub 2017 Apr 24.
Source | Abstract | Full text | Similar articles





OVERALL MANAGEMENT



Miyahira AK, Soule HR.
The 23rd Annual Prostate Cancer Foundation Scientific Retreat report.
Prostate. 2017 May 14. doi: 10.1002/pros.23366. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





PROGNOSIS AND OUTCOMES



Beckmann K, O'Callaghan M, Vincent A, Roder D, Millar J, Evans S, McNeil J, Moretti K.
Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy.
ANZ J Surg. 2017 May 4. doi: 10.1111/ans.13954. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Mamas MA, Sperrin M, Watson MC, Coutts A, Wilde K, Burton C, Kadam UT, Kwok CS, Clark AB, Murchie P, Buchan I, Hannaford PC, Myint PK.
Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland.
Eur J Heart Fail. 2017 May 3. doi: 10.1002/ejhf.822. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Maxeiner A, Kilic E, Matalon J, Friedersdorff F, Miller K, Jung K, Stephan C, Busch J.
The prostate health index PHI predicts oncological outcome and biochemical recurrence after radical prostatectomy - analysis in 437 patients.
Oncotarget. 2017 Apr 27. doi: 10.18632/oncotarget.17476. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Sampurno F, Earnest A, Millar J, Frydenberg M, Murphy D, Delprado W, Evans S.
Population-based study of grade progression in patients who harboured Gleason 3 + 3.
World J Urol. 2017 May 12. doi: 10.1007/s00345-017-2047-z. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Zhao X, Xu Z, Li H.
NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis.
Sci Rep. 2017 May 12;7(1):1875. doi: 10.1038/s41598-017-01644-0.
Source | Abstract | Full text | Similar articles




Zhou CK, Daugherty SE, Liao LM, Freedman ND, Abnet CC, Pfeiffer R, Cook MB.
Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
Cancer Prev Res (Phila). 2017 May 15. doi: 10.1158/1940-6207.CAPR-17-0033. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





TREATMENT



Beck M, Hayoz S, Ghadjar P.
Re: Radiation With or Without Antiandrogen Therapy in Recurrent Prostate Cancer.
Eur Urol. 2017 May 15. pii: S0302-2838(17)30385-8. doi: 10.1016/j.eururo.2017.05.004. [Epub ahead of print
Source | Abstract | Full text | Similar articles




Budäus L, Schiffmann J, Graefen M, Huland H, Tennstedt P, Siegmann A, Böhmer D, Budach V, Bartkowiak D, Wiegel T.
Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy : Informing the debate.
Strahlenther Onkol. 2017 May 3. doi: 10.1007/s00066-017-1140-y. [Epub ahead of print]
Source | Abstract | Full text | Similar articles | Editor's choice




Fakhrejahani F, Madan RA, Dahut WL.
Management Options for Biochemically Recurrent Prostate Cancer.
Curr Treat Options Oncol. 2017 May;18(5):26. doi: 10.1007/s11864-017-0462-4. Epub 2017 Apr 22.
Source | Abstract | Full text | Similar articles




Hoffman RM, Lo M, Clark JA, Albertsen PC, Barry MJ, Goodman M, Penson DF, Stanford JL, Stroup AM, Hamilton AS.
Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study.
J Clin Oncol. 2017 May 11:JCO2016706317. doi: 10.1200/JCO.2016.70.6317. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Holliday EB, Kuban DA, Levy LB, Bolukbasi Y, Master P, Choi S, Nguyen Q, McGuire SE, Mahmood U, Frank SJ, Hoffman KE.
Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy.
Prostate Cancer Prostatic Dis. 2017 May 2. doi: 10.1038/pcan.2017.24. [Epub ahead of print]
Source | Abstract | Full text | Similar articles | Editor's choice




Shipley WU, Seiferheld W, Lukka HR, Major PP, Heney NM, Grignon DJ, Sartor O, Patel MP, Bahary JP, Zietman AL, Pisansky TM, Zeitzer KL, Lawton CA, Feng FY, Lovett RD, Balogh AG, Souhami L, Rosenthal SA, Kerlin KJ, Dignam JJ, Pugh SL, Sandler HM; NRG Oncology RTOG.
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
N Engl J Med. 2017 Feb 2;376(5):417-428. doi: 10.1056/NEJMoa1607529.
Source | Abstract | Full text | Similar articles




Spieler B, Goldstein J, Lawrence YR, Saad A, Berger R, Ramon J, Dotan Z, Laufer M, Weiss I, Tzvang L, Poortmans P, Symon Z.
Salvage Radiation Therapy for Biochemical Failure Following Radical Prostatectomy.
Isr Med Assoc J. 2017 Jan;19(1):19-24.
Source | Abstract | Full text | Similar articles




Thompson IM Jr.
Improved Therapy for PSA Recurrence after Prostatectomy.
N Engl J Med. 2017 Feb 2;376(5):484-485. doi: 10.1056/NEJMe1614133.
Source | Abstract | Full text | Similar articles




Stöckle M.
[Is there still a role for active surveillance in prostate cancer?]
Urologe A. 2017 May 17. doi: 10.1007/s00120-017-0412-6. [Epub ahead of print]
Source | Abstract | Full text | Similar articles